Unilife +13.1% AH, strikes drug delivery supply agreement with Novartis

|About: Unilife Corporation (UNIS)|By:, SA News Editor

Shares of Unilife (UNISjump 13.1% AH after the company strikes an injectable drug delivery device supply agreement with Novartis for one of the latter's targeted early-stage pipeline drugs. Terms are confidential.

Under the agreement, Unilife will supply Novartis with a customized syringe, needle, tubing, controller and pump device to administer a clinical trial drug into a targeted organ.